These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 303878)

  • 1. Malignant lymphoma with B-lymphocyte characteristics in dogs.
    Holmberg CA; Manning JS; Osburn BI
    Am J Vet Res; 1977 Nov; 38(11):1877-9. PubMed ID: 303878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte responsiveness to mitogens and quantitation of T and B lymphocytes in canine malignant lymphoma.
    Dutta SK; Novilla MN; Bumgardner MK; Ingling A
    Am J Vet Res; 1978 Mar; 39(3):455-8. PubMed ID: 305738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feline malignant lymphomas: comparison of morphologic and immunologic characteristics.
    Holmberg CA; Manning JS; Osburn BI
    Am J Vet Res; 1976 Dec; 37(12):1455-60. PubMed ID: 793460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of canine T lymphocytes by membrane receptor to peanut agglutinin: T-lymphocyte identification in dogs with lupus-like syndrome.
    Rigal D; Bendali-Ahcène S; Monier JC; Mohana K; Fournel C
    Am J Vet Res; 1983 Sep; 44(9):1782-5. PubMed ID: 6605102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.
    Brouet JC; Labaume S; Seligmann M
    Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immunologic studies of malignant lymphoma in rhesus macaques.
    Holmberg CA; Osburn BI; Terrell TG; Manning JS
    Am J Vet Res; 1978 Mar; 39(3):469-72. PubMed ID: 416735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunologic approach to the pathology of malignant lymphomas.
    Lukes RJ
    Am J Clin Pathol; 1979 Oct; 72(4 Suppl):657-69. PubMed ID: 386777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunological classification of lymphoma and lymphocytic leukemias (author's transl)].
    Derre M; Tubiana N; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1999-2003. PubMed ID: 6256913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma.
    Mason NJ; Coughlin CM; Overley B; Cohen JN; Mitchell EL; Colligon TA; Clifford CA; Zurbriggen A; Sorenmo KU; Vonderheide RH
    Gene Ther; 2008 Jul; 15(13):955-65. PubMed ID: 18337841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A canine lymphocyte surface antigen detectable by a monoclonal antibody (DT200).
    Sarmiento UM; Valli VE
    Can J Vet Res; 1987 Jan; 51(1):110-6. PubMed ID: 2952236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias.
    Lukes RJ; Taylor CR; Parker JW; Lincoln TL; Pattengale PK; Tindle BH
    Am J Pathol; 1978 Feb; 90(2):461-86. PubMed ID: 304674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotypic classification of canine malignant lymphoma on formalin-mixed paraffin wax-embedded tissue by means of CD3 and CD79a cell markers.
    Milner RJ; Pearson J; Nesbit JW; Close P
    Onderstepoort J Vet Res; 1996 Dec; 63(4):309-13. PubMed ID: 9173362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of flow cytometric immunophenotyping to refine the cytological diagnosis of canine lymphoma.
    Comazzi S; Gelain ME
    Vet J; 2011 May; 188(2):149-55. PubMed ID: 20413335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the T200 family of glycoproteins in canine malignant lymphoma.
    Sarmiento UM; Valli VE
    Can J Vet Res; 1987 Jan; 51(1):89-94. PubMed ID: 2952238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [T- and B-lymphocytes in lymphoproliferative diseases].
    Tsveibakh AS; Gol'dman EI
    Vopr Onkol; 1978; 24(1):11-6. PubMed ID: 305684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of T and B cell populations in some lymphoproliferative disorders.
    Herzog P; Stöckbauer P
    Czech Med; 1980; 3(4):263-70. PubMed ID: 6971744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface markers on canine lymphocytes.
    Miller CH; Carbonell AR; Peng R; MacKenzie MR; Shifrine M
    Am J Vet Res; 1978 Jul; 39(7):1191-4. PubMed ID: 307932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surface markers of the lymphoid cells in non-Hodgkin's lymphoma].
    Płuzańska A; Polkowska-Kulesza E; Robak T; Kuźmicka J; Mazurowa A; Szadowska A; Woźniak L
    Acta Haematol Pol; 1980; 11(1):31-9. PubMed ID: 6966115
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunological characterization of malignant epidermotropic lymphoma cells in cutaneous infiltrates (author's transl)].
    Thivolet J; Souteyrand P; Alario A; Schmitt D; Perrot H
    Dermatologica; 1978; 157(6):357-64. PubMed ID: 363474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.